Tagged coronavirus
Press Release
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™. Read More
Press Release
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More
Press Release
A New RPO Service That Can Double Your Revenue at 40% of the Operational Cost?
Gabtech Global invites your business into the future of Recruitment Process Outsourcing. Solve the uncertainty in the times of Pandemic, get access to new talent pools and ensure faster hires at much lower operational costs. Read More
Press Release
Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'
Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2
Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.
As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity. Read More
Press Release
Point-of-Sale Fintech Company LendingUSA™ Responds to FEMA's COVID-19 Funeral Assistance Program
LendingUSA, an award-winning point-of-sale solution for consumer financing, is a major player in the funeral industry. Their team is ready to assist funeral professionals in navigating the application and reimbursement process for FEMA's new funeral assistance program. Read More
Press Release
Vaccine Centers, Municipalities and Hospitals Nationwide Are Tapping OnHold.com to Help Ease Inbound Call Burden
The nation's COVID-19 vaccine and testing centers, medical facilities, hospitals and public service municipalities are tapping OnHold.com to help ease their inbound call burden with compassionate, instructive telephone greetings and accurate on-hold messaging. Read More
Press Release
APEX HEALTH SAFETY POWERED BY SIMPLIFLYING CREATES A NEW STANDARD FOR PASSENGER WELL-BEING AND ANNOUNCES THE FIRST CERTIFIED AIRLINES
Airline-Industry-Driven Health Certification Centered Around Customers, Expected to Further Drive Global Airline Leadership in COVID-19 Safety Read More
Press Release